Journal
BIOCHEMISTRY AND CELL BIOLOGY
Volume 96, Issue 6, Pages 742-751Publisher
CANADIAN SCIENCE PUBLISHING
DOI: 10.1139/bcb-2017-0302
Keywords
bleomycin; pulmonary fibrosis; quercetin; sphingosine-1-phosphate; sphingosine kinase 1
Categories
Funding
- National Natural Science Foundation of China [81641190]
Ask authors/readers for more resources
Idiopathic pulmonary fibrosis is an agnogenic chronic disorder with high morbidity and low survival rate. Quercetin is a flavonoid found in a variety of herbs with anti-fibrosis function. In this study, bleomycin was employed to induce a pulmonary fibrosis mouse model. The quercetin administration ameliorated bleomycin-induced pulmonary fibrosis, evidenced by the expression level changes of hydroxyproline, fibronectin, alpha-smooth muscle actin, Collagen I, and Collagen III. Similar results were observed in transforming growth factor (TGF)-beta-treated human embryonic lung fibroblast (HELF). The bleomycin or TGF-beta administration caused the increase of sphingosine-1-phosphate (S1P) level in pulmonary tissue and HELF cells, as well as its activation-required kinase, sphingosine kinase 1 (SphK1), and its degradation enzyme, sphinogosine-1-phosphate lyase (S1PL). However, the increase of S1P, SphK1, and S1PL was attenuated by application of quercetin. In addition, the effect of quercetin on fibrosis was abolished by the ectopic expression of SphK1. The colocalization of SphK1/S1PL and fibroblast specific protein 1 (FSP1) suggested the roles of fibroblasts in pulmonary fibrosis. In summary, we demonstrated that quercetin ameliorated pulmonary fibrosis in vivo and in vitro by inhibiting SphK1/S1P signaling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available